My audience of 10 blog isn't going to amplify a New York Times article, but on the theory that every little bit might help...this article seemed worth sharing.

They Have Alzheimer’s. This Clinical Trial May Be a Last Hope.
In the narrow window in which patients are aware of their disease, they have sought help in clinical trials. But enrolling enough participants to make these trials count is not easy.

Alzheimer's is a heavy introduction to Monday. I'll balance that with the best interview I have read in ages - David Marchese and Stephen Fry.